Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (311-320 of 566) with videos related to

Pageof 57
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Mayo Clinic Proceedings|February 7, 2021
Coagulation Abnormalities in Light Chain AmyloidosisNadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Blood Cancer Journal|October 12, 2018
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestryLinda B Baughn, Kathryn Pearce, Dirk Larson, et al.
Blood Cancer Journal|December 6, 2022
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Pageof 57

Showing results (311-320 of 566) with videos related to

Sort By:
Pageof 57
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 13, 2025
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survivalMatthew J Rees, Nadia Toumeh, Angela Dispenzieri, et al.
American Journal of Hematology|August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasiasTaxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Mayo Clinic Proceedings|February 7, 2021
Coagulation Abnormalities in Light Chain AmyloidosisNadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Blood Cancer Journal|October 12, 2018
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestryLinda B Baughn, Kathryn Pearce, Dirk Larson, et al.
Blood Cancer Journal|December 6, 2022
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Pageof 57